STRAUB CLINIC & HOSPITAL
1. Target Overview & Investment Thesis
STRAUB CLINIC & HOSPITAL is a 159-bed suburban community hospital in HONOLULU, HI with $537.5M in net patient revenue and a 4.1% operating margin. The hospital serves a payer mix of 25.9% Medicare, 0.1% Medicaid, and 74.0% commercial.
Thesis: Undervalued. Our ML models identify $39.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 4.1% to 11.4% (+736bps).
| Net Revenue HCRIS | $537.5M |
| Current EBITDA COMPUTED | $21.8M |
| Operating Margin COMPUTED | 4.1% |
| Occupancy HCRIS | 84.6% |
| Revenue / Bed COMPUTED | $3.4M |
| Net-to-Gross HCRIS | 35.3% |
| Distress Probability ML | 36.9% |
2. Market Context & Competitive Position
HI has 26 Medicare-certified hospitals with a median operating margin of -14.7%. The target's margin of 4.1% places it above the state median. Among 10 size-comparable peers (80-318 beds), the median margin is -14.8%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (80-318), prioritizing same-state peers. 10 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| STRAUB CLINIC & HOSPITAL (Target) | HI | 159 | $537.5M | 4.1% |
| KAPIOLANI MED CTR FOR WOMEN & | HI | 253 | $437.4M | 11.9% |
| KFH-HAWAII | HI | 285 | $377.3M | -13.8% |
| MAUI MEMORIAL MEDICAL CENTER | HI | 219 | $335.5M | -3.5% |
| PALI MOMI MEDICAL CENTER | HI | 118 | $303.6M | 6.6% |
| HILO MEDICAL CENTER | HI | 194 | $263.6M | -19.5% |
| ADVENTIST HEALTH CASTLE | HI | 160 | $187.9M | -13.9% |
| KUAKINI MEDICAL CENTER | HI | 170 | $144.7M | -16.1% |
| KONA COMMUNITY HOSPITAL | HI | 83 | $105.2M | -37.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $39.6M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $11.3M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $10.8M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $10.6M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $6.5M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $344K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $21.8M |
| + RCM Uplift | +$39.6M |
| Pro Forma EBITDA | $61.4M |
| Current Margin | 4.1% |
| Pro Forma Margin | 11.4% |
| WC Released (1x) | $20.6M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $33.6M | $539.5M | 16.08x | 74.3% |
| Base (11x exit) | 10.0x | 11.0x | $33.6M | $604.4M | 18.01x | 78.3% |
| Bull Case | 9.0x | 11.0x | $30.2M | $745.9M | 24.70x | 89.9% |
| Bull (12x exit) | 9.0x | 12.0x | $30.2M | $822.6M | 27.24x | 93.7% |
| Bear Case | 11.0x | 10.0x | $36.9M | $330.8M | 8.96x | 55.0% |
| Bear (11x exit) | 11.0x | 11.0x | $36.9M | $375.9M | 10.18x | 59.1% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 10 hospitals with 80-318 beds
- Same-state prioritization (n=11)
- Comp margins: P25=-18.6% / P50=-14.8% / P75=-6.1%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.